Trump drug price executive order includes MFN pricing

WASHINGTON — The Trump administration on Monday unveiled a sweeping plan to try to lower prescription drug prices, one that calls for not only basing prices on those paid by other countries but also tighter enforcement of anti-competitive practices. The plan also leaves the door open to an expansion of medications from overseas.

The actions are far more aggressive than those in President Trump’s first term — and are meant to push drugmakers to make a deal with the administration or face consequences from agencies across the federal government. 

The Department of Health and Human Services will negotiate direct-to-consumer prices “where appropriate,” aiming for prices comparable to those in other countries, a White House official said in a briefing for reporters speaking on condition of anonymity.